BioLineRx (BLRX) Announces 50M Share Offering at $0.20/sh

Go back to BioLineRx (BLRX) Announces 50M Share Offering at $0.20/sh

BioLineRx Announces $10 Million Registered Direct Offering

January 6, 2025 8:57 AM EST

TEL AVIV, Israel, Jan. 6, 2025 /PRNewswire/ -- BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has entered into definitive agreements for the purchase of an aggregate of... More